James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

4 Reasons the Next 12 Months Will Make or Break AT&T Stock

AT&T has a handful of clear objectives to focus on if the current rally from T stock is to continue into the latter half of the year.

3 Big Stock Charts for Tuesday: Centene, Boston Scientific and Hewlett Packard Enterprise

The stock charts of HPE, CNC and BSX are going to get the new trading week started on the verge of major moves.

Cronos Stock May Be the Least Trusted Name in Cannabis

CRON stock continues to rally with all other marijuana stocks, but there's something about Cronos Group that a lot of people just can't shrug off.

Aurora Cannabis Stock Starts To Distinguish Itself From The Pot-Stock Pack

ACB stock is still a risky bet, but Aurora Cannabis is showing that it's more of a 'real company' than most of its marijuana peers.

3 Big Stock Charts for Friday: Alaska Air Group, Comcast and Moody’s

The stock charts of ALK, MCO and CMCSA stock are poised to end the trading week at pivotal levels, or past their tipping points.

5 Reasons to Invest In Stocks Versus Debt

The stocks vs bonds debate rages on. But, there's no getting around the fact that stocks always win in the end. Balance of the two is the key.

3 Big Stock Charts for Thursday: Nordstrom, Cadence Design Systems and Under Armour

The stock charts of UAA, JWN and CDNS stock have been put under the trading microscope for some scrutiny. Here's what you need to know.

Even with a Pharma Arm, Canopy Growth Stock Is About Recreational Use

It's not a great reason in and of itself to buy CGC stock , but Canopy Growth does have an overlooked presence in the medical cannabis arena.

If Nio Stock Has Disappointed You, Read This

Nio stock may be a poor post-IPO performer, but that was predictable. With time, NIO should prove to be a great investment.

3 Big Stock Charts for Wednesday: Oracle, Lamb Weston Holdings and TJX Companies

The stock charts of TJX, LW and ORCL are on the brink of big moves as we move into the middle of the trading week.